期刊
RADIOTHERAPY AND ONCOLOGY
卷 88, 期 2, 页码 177-182出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2008.03.005
关键词
anaplastic glioma; radiotherapy; chemotherapy; outcome
Outcome after radiochemotherapy (RCHT) with temozolomide (TMZ) versus radiotherapy (RT) for WHO grade III astrocytic tumors was evaluated. No significant difference in overall survival or progression-free survival between both groups was calculated. RCHT seems not to result in an improved outcome. Further randomized studies are needed to support these results. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据